A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme

Health Technology Assessment : HTA
K ClaxtonS Palmer

Abstract

To demonstrate the benefits of using appropriate decision-analytic methods and value of information analysis (DA-VOI). Also to establish the feasibility and implications of applying these methods to inform the prioritisation process of the NHS Health Technology Assessment (HTA) programme, and possibly extending their use therein. Three research topics that were considered by the HTA panels in the September 2002 and February 2003 prioritisation rounds. A brief and non-technical overview of DA-VOI methods was circulated to the panels and Prioritisation Strategy Group (PSG). For each case study the results were presented to the panels and the PSG in the form of brief case-study reports. Feedback on the DA-VOI analysis and its presentation was obtained in the form of completed questionnaires from panel members, and reports from panel senior lecturers and PSG members. Although none of the research topics identified met all of the original selection criteria for inclusion as case studies in the pilot, it was possible to construct appropriate decision-analytic models and conduct probabilistic analysis for each topic. In each case, the tasks were completed within the time-frame required by the existing HTA research prioritisation proce...Continue Reading

Citations

Aug 5, 2014·Current Opinion in Otolaryngology & Head and Neck Surgery·Brian J McKinnon
Oct 23, 2008·Clinical & Experimental Metastasis·Eric L KaijzelClemens W G M Löwik
Jun 8, 2012·Journal of General Internal Medicine·Thomas A TrikalinosWilliam F Lawrence
Aug 23, 2005·International Journal of Technology Assessment in Health Care·Su GolderLaura Ginnelly
Dec 25, 2009·International Journal of Technology Assessment in Health Care·Sheila TurnerUNKNOWN European network for Health Technology Assessment (EUnetHTA)
May 9, 2012·International Journal of Technology Assessment in Health Care·Andres Pichon-RiviereMichael Drummond
Aug 4, 2005·Applied Health Economics and Health Policy·Laura GinnellySue Golder
Nov 29, 2005·Applied Health Economics and Health Policy·Stavros Petrou, Ron Gray
Jun 16, 2006·Applied Health Economics and Health Policy·Josep Maria HaroFrank Windmeijer
Aug 2, 2005·Medical Care·Michael Drummond, Mark Sculpher
Jul 24, 2013·PharmacoEconomics·Christopher McCabePeter Hall
Apr 25, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·W H RogowskiS Palmer
Dec 10, 2013·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Uwe SiebertKarl Claxton
Sep 25, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Lazaros Andronis
Jun 21, 2011·Journal of Clinical Epidemiology·Alexander TsertsvadzeDavid Moher
Apr 30, 2011·Contemporary Clinical Trials·Susan CunninghamFriedy Luther
Jan 18, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Isaac Corro RamosMaiwenn J Al
Jul 27, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Peter S HallDavid A Cameron
Apr 10, 2010·Journal of Health Economics·Jeremy E OakleyJim Chilcott
Dec 5, 2009·Gaceta sanitaria·Julio López BastidaJaume Puig-Junoy
Feb 12, 2009·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·C RaoT Athanasiou
Jun 3, 2009·BJOG : an International Journal of Obstetrics and Gynaecology·O EddamaJ E Norman
Nov 21, 2008·Journal of Evaluation in Clinical Practice·Monica Ortendahl
Aug 31, 2006·Health Economics·Alan BrennanRuth Davies
Jul 13, 2012·Statistics in Medicine·Verena RoloffAlex J Sutton
Jan 31, 2006·Addictive Behaviors·Monica Ortendahl
Jun 28, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nick AdlardEmma Frew
Dec 2, 2014·Critical Care : the Official Journal of the Critical Care Forum·Marta O SoaresStephen J Palmer
Jun 8, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Syed MohiuddinIain Bruce
Mar 9, 2010·Health Research Policy and Systems·Ludovic ReveizRodrigo Pardo
May 16, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Claire McKennaStephen Palmer
Oct 13, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Bas Groot KoerkampM G Myriam Hunink
Mar 30, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Laura BojkeKeith Abrams
Jul 16, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jan B OostenbrinkMaureen P M H Rutten-van Mölken
Jun 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Laura BojkeStephen Palmer
May 13, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mart P Janssen, Hendrik Koffijberg
Sep 10, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Martin Hoyle
Oct 16, 2016·Biometrical Journal. Biometrische Zeitschrift·Juha Karvanen, Mikko J Sillanpää

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Technology Assessment in Health Care
David Hailey
International Journal of Technology Assessment in Health Care
Carlo FavarettiWalter Ricciardi
International Journal of Technology Assessment in Health Care
Caroline Weill, David Banta
International Journal of Technology Assessment in Health Care
Madeleine De Rosas-Valera
© 2022 Meta ULC. All rights reserved